Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Disease relapse after bone marrow transplantation occurs when the original condition for which the transplant was performed returns. This is a serious concern that requires careful monitoring through specialized laboratory testing to detect early signs of the disease coming back.
This specialized test uses fluorescent markers to identify X and Y chromosomes in blood cells, allowing doctors to distinguish between donor and recipient cells after transplant. When the test shows a higher percentage of recipient cells compared to donor cells, it may indicate that the original disease is returning, signaling a potential relapse that requires immediate medical attention.
After a bone marrow transplant from a donor of the opposite sex, specialized blood tests can track the balance between donor and recipient cells. A shift toward more recipient cells may indicate that the original disease is returning, making early detection crucial for prompt intervention.
FISH (Fluorescence In Situ Hybridization) technology provides precise monitoring of cell populations after transplant. This testing is fundamental for transplant patients as it offers an early warning system for disease recurrence, allowing healthcare providers to adjust treatment plans before clinical symptoms appear.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment. This test is specifically designed for patients who have received bone marrow transplants from donors of the opposite sex.